| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1127644725 |
| P356 | DOI | 10.1002/DMRR.3336 |
| P698 | PubMed publication ID | 32415805 |
| P50 | author | Azam Hosseinzadeh | Q56722221 |
| P2093 | author name string | Karim Hemati | |
| Saeed Mehrzadi | |||
| Mohammad Hossein Pourhanifeh | |||
| Ehsan Dehdashtian | |||
| P2860 | cites work | Aldose reductase inhibitors: therapeutic implications for diabetic complications | Q93945663 |
| Sirtuins in Renal Health and Disease | Q94073889 | ||
| α-Glucosidase and α-amylase inhibitory activities of guava leaves | Q104923832 | ||
| Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats | Q42512578 | ||
| Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway | Q42582396 | ||
| Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway | Q42699497 | ||
| The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy | Q42707470 | ||
| Resveratrol attenuates early diabetic nephropathy by down-regulating glutathione s-transferases Mu in diabetic rats. | Q42710707 | ||
| Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice | Q42715172 | ||
| The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats | Q42717288 | ||
| SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. | Q42733843 | ||
| The proteasome inhibitor Velcade enhances rather than reduces disease in mouse hepatitis coronavirus-infected mice. | Q42738022 | ||
| Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling | Q42744612 | ||
| Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats | Q42752177 | ||
| Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway | Q42799494 | ||
| Gallic acid induces GLUT4 translocation and glucose uptake activity in 3T3-L1 cells | Q42831600 | ||
| Protective effect of berberine on renal fibrosis caused by diabetic nephropathy | Q42835125 | ||
| Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway | Q42963879 | ||
| Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury | Q43071829 | ||
| Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK. | Q43120546 | ||
| Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway | Q43443950 | ||
| Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium | Q43780419 | ||
| Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats. | Q44073636 | ||
| Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin | Q44532250 | ||
| Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats | Q44558511 | ||
| Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart | Q44586825 | ||
| Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes | Q44599812 | ||
| The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts. | Q45342329 | ||
| Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel | Q46096343 | ||
| Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. | Q46096844 | ||
| Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway | Q46131293 | ||
| (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation. | Q46296189 | ||
| Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia | Q46315752 | ||
| Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle | Q46323577 | ||
| Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway | Q46409671 | ||
| Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice | Q46460973 | ||
| Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling | Q46480430 | ||
| Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats | Q46494161 | ||
| Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model | Q46543065 | ||
| Improvement of inflammatory responses associated with NF-kappa B pathway in kidneys from diabetic rats | Q46606039 | ||
| Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy | Q46650693 | ||
| Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats | Q46803025 | ||
| Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats | Q46918513 | ||
| The Effect of Dietary Supplementation With Curcumin on Redox Status and Nrf2 Activation in Patients With Nondiabetic or Diabetic Proteinuric Chronic Kidney Disease: A Pilot Study. | Q47874550 | ||
| Antidiabetic plant-derived nutraceuticals: a critical review | Q47902465 | ||
| Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes | Q48006848 | ||
| Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1. | Q48146151 | ||
| Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway | Q49602918 | ||
| Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys | Q49923281 | ||
| Concomitant administration of resveratrol and insulin protects against diabetes mellitus type-1-induced renal damage and impaired function via an antioxidant-mediated mechanism and up-regulation of Na+/K+-ATPase | Q50046892 | ||
| Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy | Q50098217 | ||
| Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? | Q50657801 | ||
| Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways. | Q50967280 | ||
| Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy. | Q51191631 | ||
| Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in glomerular mesangial cells. | Q51294860 | ||
| Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats. | Q51299721 | ||
| Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes. | Q51303525 | ||
| Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy. | Q51347304 | ||
| Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats. | Q51348247 | ||
| Antidiabetic activity and molecular docking of fructooligosaccharides produced by Aureobasidium pullulans in poloxamer-407-induced T2DM rats. | Q51349515 | ||
| Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin. | Q51358502 | ||
| Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21. | Q51429794 | ||
| Natural approaches in metabolic syndrome management. | Q51758644 | ||
| Effects of a novel curcumin derivative on the functions of kidney in streptozotocin-induced type 2 diabetic rats. | Q52628851 | ||
| Curcumin and diabetes: a systematic review | Q21284809 | ||
| Identification of a novel gene encoding an insulin-responsive glucose transporter protein | Q24338976 | ||
| Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin? | Q26796638 | ||
| AMPK: a target for drugs and natural products with effects on both diabetes and cancer | Q27002908 | ||
| Pam17 is required for architecture and translocation activity of the mitochondrial protein import motor | Q27935671 | ||
| Activation of phosphoinositide 3-kinase in response to high glucose leads to regulation of reactive oxygen species-related nuclear factor-kappaB activation and cyclooxygenase-2 expression in mesangial cells | Q28169077 | ||
| Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine | Q28253310 | ||
| Targeting proteins for degradation | Q28261886 | ||
| Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice | Q28274074 | ||
| A genomic and functional inventory of deubiquitinating enzymes | Q28284911 | ||
| Gedunin and Azadiradione: Human Pancreatic Alpha-Amylase Inhibiting Limonoids from Neem (Azadirachta indica) as Anti-Diabetic Agents | Q28550293 | ||
| Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study | Q28566557 | ||
| Caffeine acutely activates 5'adenosine monophosphate-activated protein kinase and increases insulin-independent glucose transport in rat skeletal muscles | Q28573201 | ||
| SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model | Q28817614 | ||
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| AMPK: a nutrient and energy sensor that maintains energy homeostasis | Q29615410 | ||
| Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy | Q93026456 | ||
| Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis | Q93179580 | ||
| ACE inhibitors and ARBs: Managing potassium and renal function | Q93196072 | ||
| Fat and beyond: the diverse biology of PPARgamma | Q29615416 | ||
| Cancer nanotechnology: opportunities and challenges | Q29615481 | ||
| Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage | Q29616101 | ||
| PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism | Q33283063 | ||
| The search for novel human pancreatic alpha-amylase inhibitors: high-throughput screening of terrestrial and marine natural product extracts | Q33316144 | ||
| Bioavailability and delivery of nutraceuticals using nanotechnology | Q33584133 | ||
| Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy | Q33589104 | ||
| Control of mitochondrial biogenesis and function by the ubiquitin-proteasome system | Q33628850 | ||
| HRD1-Mediated IGF-1R Ubiquitination Contributes to Renal Protection of Resveratrol in db/db Mice | Q33631382 | ||
| Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study | Q33647372 | ||
| Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC | Q33745769 | ||
| Treatment of diabetic kidney disease: current and future targets | Q33907249 | ||
| Transcription factor-kappa B (NF-kappa B) and renal disease. | Q34135831 | ||
| Nanomedicine--challenge and perspectives | Q34247073 | ||
| Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation | Q34305376 | ||
| Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models | Q34399505 | ||
| Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation | Q34666690 | ||
| Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy. | Q34738579 | ||
| Targeting JNK by a new curcumin analog to inhibit NF-kB-mediated expression of cell adhesion molecules attenuates renal macrophage infiltration and injury in diabetic mice | Q35048212 | ||
| Resveratrol attenuates diabetic nephropathy via modulating angiogenesis | Q35061522 | ||
| Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase | Q35147432 | ||
| Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db/db mice | Q35190860 | ||
| A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy | Q35192219 | ||
| Molecular docking studies of (4Z, 12Z)-cyclopentadeca-4, 12-dienone from Grewia hirsuta with some targets related to type 2 diabetes | Q35606228 | ||
| Recruitment of Hsp70 chaperones: a crucial part of viral survival strategies. | Q35831258 | ||
| Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats | Q35995332 | ||
| The protective effects of oral low-dose quercetin on diabetic nephropathy in hypercholesterolemic mice. | Q36018270 | ||
| PPARgamma in human and mouse physiology | Q36063081 | ||
| Pathogenetic mechanisms of diabetic nephropathy | Q36153062 | ||
| Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats | Q36159004 | ||
| Plasminogen activator inhibitor-1 and diabetic nephropathy. | Q36262378 | ||
| Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy. | Q36510007 | ||
| Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy | Q36707919 | ||
| Regulation of interplay between autophagy and apoptosis in the diabetic heart: new role of AMPK. | Q36769740 | ||
| Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy | Q36994616 | ||
| Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. | Q53052202 | ||
| Melatonin nephroprotective action in Zucker diabetic fatty rats involves its inhibitory effect on NADPH oxidase. | Q53295837 | ||
| Renal function after new treatment with renin-angiotensin system blockers. | Q53447763 | ||
| Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation. | Q53453918 | ||
| Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. | Q53589254 | ||
| Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. | Q54782198 | ||
| Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway. | Q55108878 | ||
| The Role of Nutraceuticals in Statin Intolerant Patients | Q56373574 | ||
| Resveratrol effect on patients with non-alcoholic fatty liver disease: A matter of dose and treatment length | Q56374599 | ||
| Signaling of Mitochondrial Biogenesis following Oxidant Injury | Q56777104 | ||
| Prevalence of nephropathy in type 1 diabetes in the Arab world: A systematic review and meta-analysis | Q57657558 | ||
| Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment? | Q57703670 | ||
| Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress | Q61837710 | ||
| A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy | Q64018940 | ||
| Combination of melatonin and certain drugs for treatment of diabetic nephropathy in streptozotocin-induced diabetes in rats. | Q64915804 | ||
| The effect of a new specific ?-amylase inhibitor on post-prandial glucose and insulin excursions in normal subjects and Type 2 (non-insulin-dependent) diabetic patients | Q70362196 | ||
| Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex | Q73171123 | ||
| High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent | Q73382583 | ||
| Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan | Q73969333 | ||
| Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats | Q74485663 | ||
| Melatonin and taurine reduce early glomerulopathy in diabetic rats | Q77416605 | ||
| Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats | Q79142160 | ||
| Rapamycin prevents early steps of the development of diabetic nephropathy in rats | Q80726615 | ||
| Nutraceutical resources for diabetes prevention--an update | Q80979570 | ||
| Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy | Q81371324 | ||
| Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats | Q82096732 | ||
| Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells | Q82123093 | ||
| Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats | Q82299221 | ||
| Renoprotective effects of berberine and its potential effect on the expression of β-arrestins and intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in streptozocin-diabetic nephropathy rats | Q86619116 | ||
| Meta-analysis: the efficacy and safety of combined treatment with ARB and ACEI on diabetic nephropathy | Q86811859 | ||
| Renoprotective effect of berberine on type 2 diabetic nephropathy in rats | Q87103959 | ||
| Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy | Q87216947 | ||
| Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies | Q87643622 | ||
| The renoprotective effects of berberine via the EP4-Gαs-cAMP signaling pathway in different stages of diabetes in rats | Q87923423 | ||
| Toxicity Potential of Nutraceuticals | Q89208355 | ||
| Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial | Q89460761 | ||
| Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC-1α mediated attenuation of mitochondrial oxidative stress | Q91310866 | ||
| Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy | Q91429858 | ||
| Evaluating the protective effects of melatonin on di(2-ethylhexyl) phthalate-induced testicular injury in adult mice | Q91647136 | ||
| Ramipril and resveratrol co-treatment attenuates RhoA/ROCK pathway-regulated early-stage diabetic nephropathy-associated glomerulosclerosis in streptozotocin-induced diabetic rats | Q91817215 | ||
| Nelumbo nucifera leaves extract attenuate the pathological progression of diabetic nephropathy in high-fat diet-fed and streptozotocin-induced diabetic rats | Q92030699 | ||
| Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice | Q92442714 | ||
| Molecular Aspects of Melatonin Treatment in Tinnitus: A Review | Q92497231 | ||
| Resveratrol Protects Against Post-Contrast Acute Kidney Injury in Rabbits With Diabetic Nephropathy | Q92556658 | ||
| Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway | Q92906966 | ||
| The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease | Q37054679 | ||
| Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice | Q37210162 | ||
| New therapeutic agents in diabetic nephropathy | Q37559164 | ||
| Resveratrol Prevention of Diabetic Nephropathy Is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-κB Pathway. | Q37615803 | ||
| The many faces of the mitochondrial TIM23 complex | Q37684145 | ||
| Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy | Q37736609 | ||
| Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice | Q37741992 | ||
| Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. | Q37871339 | ||
| Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state | Q37955514 | ||
| Molecular understanding of curcumin in diabetic nephropathy | Q38104867 | ||
| Renal protective effects of resveratrol | Q38174888 | ||
| Angiotensin-converting enzyme inhibitor-induced angioedema | Q38233526 | ||
| Effect of curcumin on rats/mice with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials. | Q38245811 | ||
| Type 2 diabetes mellitus: Role of melatonin and oxidative stress | Q38275753 | ||
| Protein translocation channel of mitochondrial inner membrane and matrix-exposed import motor communicate via two-domain coupling protein | Q38358839 | ||
| The Nutraceutical Bioavailability Classification Scheme: Classifying Nutraceuticals According to Factors Limiting their Oral Bioavailability. | Q38364262 | ||
| Experimental and clinical aspects of melatonin and clock genes in diabetes | Q38436840 | ||
| Mitochondria: a therapeutic target in acute kidney injury | Q38579303 | ||
| Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies | Q38621266 | ||
| Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression | Q38661556 | ||
| Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice | Q38697493 | ||
| Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway | Q38701033 | ||
| Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis | Q38729813 | ||
| Thioredoxin-Interacting Protein Mediates NLRP3 Inflammasome Activation Involved in the Susceptibility to Ischemic Acute Kidney Injury in Diabetes. | Q38729962 | ||
| Melatonin Attenuates Contrast-Induced Nephropathy in Diabetic Rats: The Role of Interleukin-33 and Oxidative Stress | Q38738488 | ||
| Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat. | Q38794575 | ||
| Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy | Q38855746 | ||
| Combined potentiating action of phytochemical(s) from Cinnamomum tamala and Aloe vera for their anti-diabetic and insulinomimetic effect using in vivo rat and in vitro NIH/3T3 cell culture system | Q38925777 | ||
| Health-beneficial nutraceuticals-myth or reality? | Q39030138 | ||
| Resveratrol is a class IA phosphoinositide 3-kinase inhibitor | Q39253076 | ||
| Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain | Q39316066 | ||
| High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. | Q39412268 | ||
| Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states | Q40250572 | ||
| Omega-3 fatty acids decrease protein kinase expression in human breast cancer cells | Q40779994 | ||
| Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. | Q41854992 | ||
| Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling. | Q42177918 | ||
| P921 | main subject | diabetic nephropathy | Q1129105 |
| P577 | publication date | 2020-05-16 | |
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | Therapeutic Application of Nutraceuticals in Diabetic Nephropathy: Current Evidence and Future Implications |
Search more.